Portfolio (Quarterly)
Guide ↗
GordonMD Global Investments LP
· CIK 0002039349| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 4,391,818.0 | $41.3M | 29.59% | NEW | — | $9.40 | -7.8% |
| 2 | TEVA | TEVA PHARMACEUTICAL INDS LTD | Healthcare | 769,550.0 | $24.0M | 17.22% | NEW | — | $31.21 | +9.2% |
| 3 | BLCO | BAUSCH PLUS LOMB CORP | Healthcare | 613,472.0 | $10.5M | 7.51% | NEW | — | $17.08 | -6.8% |
| 4 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 224,135.0 | $10.4M | 7.48% | NEW | — | $46.55 | -20.9% |
| 5 | AMGN | AMGEN INC | Healthcare | 23,212.0 | $7.6M | 5.45% | NEW | — | $327.31 | +3.7% |
| 6 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 329,101.0 | $7.6M | 5.43% | NEW | — | $23.00 | +1.7% |
| 7 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 1,330,901.0 | $7.3M | 5.25% | NEW | — | $5.50 | -0.2% |
| 8 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 930,317.0 | $5.6M | 4.02% | NEW | — | $6.03 | +52.4% |
| 9 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 66,680.0 | $5.5M | 3.91% | NEW | — | $81.88 | -24.0% |
| 10 | INCY | INCYTE CORP | Healthcare | 54,500.0 | $5.4M | 3.86% | NEW | — | $98.77 | -1.6% |
| 11 | INSM | INSMED INC | Healthcare | 28,587.0 | $5.0M | 3.57% | NEW | — | $174.04 | -39.0% |
| 12 | PYXS | PYXIS ONCOLOGY INC | Healthcare | 4,121,870.0 | $4.7M | 3.40% | NEW | — | $1.15 | +70.4% |
| 13 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 170,307.0 | $4.6M | 3.32% | NEW | — | $27.16 | +13.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%